메뉴 건너뛰기




Volumn 14, Issue 12, 2013, Pages e562-e570

Management of sarcoma in the asia-pacific region: Resource-stratified guidelines

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MESNA; METHOTREXATE; PACLITAXEL; PAZOPANIB; TRABECTEDIN; VINCRISTINE;

EID: 84886707750     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(13)70475-3     Document Type: Review
Times cited : (30)

References (115)
  • 3
    • 77954337682 scopus 로고    scopus 로고
    • Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    • Casali PG, Blay JY Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010, 21(suppl 5):v198-v203.
    • (2010) Ann Oncol , vol.21 , Issue.SUPPL. 5 , pp. 5198-5203
    • Casali, P.G.1    Blay, J.Y.2
  • 4
    • 77954333247 scopus 로고    scopus 로고
    • Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    • Hogendoorn PC, Athanasou N, Bielack S, et al. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010, 21(suppl 5):v204-v213.
    • (2010) Ann Oncol , vol.21 , Issue.SUPPL. 5 , pp. 5204-5213
    • Hogendoorn, P.C.1    Athanasou, N.2    Bielack, S.3
  • 5
    • 66549093802 scopus 로고    scopus 로고
    • Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up
    • Bielack S, Carrle D, Casali PG Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009, 20(suppl 4):137-139.
    • (2009) Ann Oncol , vol.20 , Issue.SUPPL. 4 , pp. 137-139
    • Bielack, S.1    Carrle, D.2    Casali, P.G.3
  • 6
    • 66649094233 scopus 로고    scopus 로고
    • Ewing's sarcoma of the bone: ESMO clinical recommendations for diagnosis, treatment and follow-up
    • Paulussen M, Bielack S, Jurgens H, Casali PG Ewing's sarcoma of the bone: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009, 20(suppl 4):140-142.
    • (2009) Ann Oncol , vol.20 , Issue.SUPPL. 4 , pp. 140-142
    • Paulussen, M.1    Bielack, S.2    Jurgens, H.3    Casali, P.G.4
  • 7
    • 77953502245 scopus 로고    scopus 로고
    • Guidelines for the management of soft tissue sarcomas
    • Grimer R, Judson I, Peake D, Seddon B Guidelines for the management of soft tissue sarcomas. Sarcoma 2010, 2010:506182.
    • (2010) Sarcoma , vol.2010 , pp. 506182
    • Grimer, R.1    Judson, I.2    Peake, D.3    Seddon, B.4
  • 8
    • 79952215751 scopus 로고    scopus 로고
    • UK guidelines for the management of bone sarcomas
    • Grimer R, Athanasou N, Gerrand C, et al. UK guidelines for the management of bone sarcomas. Sarcoma 2010, 2010:317462.
    • (2010) Sarcoma , vol.2010 , pp. 317462
    • Grimer, R.1    Athanasou, N.2    Gerrand, C.3
  • 9
    • 66149135224 scopus 로고    scopus 로고
    • International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons
    • Mirabello L, Troisi RJ, Savage SA International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer 2009, 125:229-234.
    • (2009) Int J Cancer , vol.125 , pp. 229-234
    • Mirabello, L.1    Troisi, R.J.2    Savage, S.A.3
  • 10
    • 0028084916 scopus 로고
    • International variations in the incidence of childhood soft-tissue sarcomas
    • Stiller C, Parkint D International variations in the incidence of childhood soft-tissue sarcomas. Paediatr Perinat Epidemiol 1994, 8:107-119.
    • (1994) Paediatr Perinat Epidemiol , vol.8 , pp. 107-119
    • Stiller, C.1    Parkint, D.2
  • 11
    • 0032248432 scopus 로고    scopus 로고
    • International incidence of childhood cancer, vol. II
    • Parkin D, Kramarova E, Draper G, et al. International incidence of childhood cancer, vol. II. IARC Sci Publ 1998, 144:1-391.
    • (1998) IARC Sci Publ , vol.144 , pp. 1-391
    • Parkin, D.1    Kramarova, E.2    Draper, G.3
  • 12
    • 35649014764 scopus 로고    scopus 로고
    • International patterns of cancer incidence in adolescents
    • Stiller CA International patterns of cancer incidence in adolescents. Cancer Treat Rev 2007, 33:631-645.
    • (2007) Cancer Treat Rev , vol.33 , pp. 631-645
    • Stiller, C.A.1
  • 13
    • 84886699326 scopus 로고    scopus 로고
    • Central Intelligence Agency, (accessed Sept 10, 2013).
    • The world factbook 2013-14 Central Intelligence Agency, (accessed Sept 10, 2013). https://www.cia.gov/library/publications/the-world-factbook/index.html.
    • The world factbook 2013-14
  • 14
    • 79251619229 scopus 로고    scopus 로고
    • Health and health-care systems in southeast Asia: diversity and transitions
    • Chongsuvivatwong V, Phua KH, Yap MT, et al. Health and health-care systems in southeast Asia: diversity and transitions. Lancet 2011, 377:429-437.
    • (2011) Lancet , vol.377 , pp. 429-437
    • Chongsuvivatwong, V.1    Phua, K.H.2    Yap, M.T.3
  • 16
    • 56449100677 scopus 로고    scopus 로고
    • Guideline implementation for breast healthcare in low-income and middle-income countries
    • Anderson BO, Yip CH, Smith RA, et al. Guideline implementation for breast healthcare in low-income and middle-income countries. Cancer 2008, 113:2221-2243.
    • (2008) Cancer , vol.113 , pp. 2221-2243
    • Anderson, B.O.1    Yip, C.H.2    Smith, R.A.3
  • 17
    • 71249155601 scopus 로고    scopus 로고
    • Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009
    • Tangjitgamol S, Anderson BO, See HT, et al. Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009, 10:1119-1127.
    • (2009) Lancet Oncol , vol.10 , pp. 1119-1127
    • Tangjitgamol, S.1    Anderson, B.O.2    See, H.T.3
  • 18
    • 71249126197 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009
    • Poon D, Anderson BO, Chen LT, et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009, 10:1111-1118.
    • (2009) Lancet Oncol , vol.10 , pp. 1111-1118
    • Poon, D.1    Anderson, B.O.2    Chen, L.T.3
  • 19
    • 71549117595 scopus 로고    scopus 로고
    • First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009
    • Soo RA, Anderson BO, Cho BC, et al. First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009, 10:1102-1110.
    • (2009) Lancet Oncol , vol.10 , pp. 1102-1110
    • Soo, R.A.1    Anderson, B.O.2    Cho, B.C.3
  • 20
    • 71249097862 scopus 로고    scopus 로고
    • Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009
    • Kwong YL, Anderson BO, Advani R, Kim WS, Levine AM, Lim ST Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009, 10:1093-1101.
    • (2009) Lancet Oncol , vol.10 , pp. 1093-1101
    • Kwong, Y.L.1    Anderson, B.O.2    Advani, R.3    Kim, W.S.4    Levine, A.M.5    Lim, S.T.6
  • 21
    • 71249160153 scopus 로고    scopus 로고
    • Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009
    • Wee JT, Anderson BO, Corry J, et al. Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009, 10:1086-1092.
    • (2009) Lancet Oncol , vol.10 , pp. 1086-1092
    • Wee, J.T.1    Anderson, B.O.2    Corry, J.3
  • 22
    • 71549153340 scopus 로고    scopus 로고
    • Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009
    • Wong NS, Anderson BO, Khoo KS, Ang PT, Yip CH, Lu YS, et al. Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009, 10:1077-1085.
    • (2009) Lancet Oncol , vol.10 , pp. 1077-1085
    • Wong, N.S.1    Anderson, B.O.2    Khoo, K.S.3    Ang, P.T.4    Yip, C.H.5    Lu, Y.S.6
  • 23
    • 84868128705 scopus 로고    scopus 로고
    • Supportive, palliative, and end-of-life care for patients with cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012
    • Payne S, Chan N, Davies A, Poon E, Connor S, Goh C Supportive, palliative, and end-of-life care for patients with cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol 2012, 13:e492-e500.
    • (2012) Lancet Oncol , vol.13
    • Payne, S.1    Chan, N.2    Davies, A.3    Poon, E.4    Connor, S.5    Goh, C.6
  • 24
    • 84868089265 scopus 로고    scopus 로고
    • Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012
    • Chiong E, Tay MH, Tan MH, et al. Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol 2012, 13:e482-e491.
    • (2012) Lancet Oncol , vol.13
    • Chiong, E.1    Tay, M.H.2    Tan, M.H.3
  • 25
    • 84868126903 scopus 로고    scopus 로고
    • Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012
    • Ku G, Tan IB, Yau T, Boku N, Laohavinij S, Cheng AL, et al. Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol 2012, 13:e470-e481.
    • (2012) Lancet Oncol , vol.13
    • Ku, G.1    Tan, I.B.2    Yau, T.3    Boku, N.4    Laohavinij, S.5    Cheng, A.L.6
  • 26
    • 0742300931 scopus 로고    scopus 로고
    • National Institute for Health and Clinical Excellence, (accessed Aug 12, 2013).
    • Guidance on cancer services-improving outcomes for people with sarcoma National Institute for Health and Clinical Excellence, (accessed Aug 12, 2013). http://www.nice.org.uk/nicemedia/live/10903/28938/28938.pdf.
    • Guidance on cancer services-improving outcomes for people with sarcoma
  • 28
    • 17644424627 scopus 로고    scopus 로고
    • National survival trends of young adults with sarcoma
    • Bleyer A, Montello M, Budd T, Saxman S National survival trends of young adults with sarcoma. Cancer 2005, 103:1891-1897.
    • (2005) Cancer , vol.103 , pp. 1891-1897
    • Bleyer, A.1    Montello, M.2    Budd, T.3    Saxman, S.4
  • 29
    • 78650445486 scopus 로고    scopus 로고
    • Adolescent and young adult oncology: an emerging field
    • Thomas DM, Albritton KH, Ferrari A Adolescent and young adult oncology: an emerging field. J Clin Oncol 2010, 28:4781-4782.
    • (2010) J Clin Oncol , vol.28 , pp. 4781-4782
    • Thomas, D.M.1    Albritton, K.H.2    Ferrari, A.3
  • 30
    • 0035690203 scopus 로고    scopus 로고
    • Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation
    • Picci P, Vanel D, Briccoli A, et al. Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation. Ann Oncol 2001, 12:1601-1604.
    • (2001) Ann Oncol , vol.12 , pp. 1601-1604
    • Picci, P.1    Vanel, D.2    Briccoli, A.3
  • 31
    • 49549103084 scopus 로고    scopus 로고
    • Imaging strategy for detecting lung metastases at presentation in patients with soft tissue sarcomas
    • Christie-Large M, James SL, Tiessen L, Davies AM, Grimer RJ Imaging strategy for detecting lung metastases at presentation in patients with soft tissue sarcomas. Eur J Cancer 2008, 44:1841-1845.
    • (2008) Eur J Cancer , vol.44 , pp. 1841-1845
    • Christie-Large, M.1    James, S.L.2    Tiessen, L.3    Davies, A.M.4    Grimer, R.J.5
  • 32
    • 79551511748 scopus 로고    scopus 로고
    • ACR Appropriateness Criteria screening for pulmonary metastases
    • Mohammed TL, Chowdhry A, Reddy GP, et al. ACR Appropriateness Criteria screening for pulmonary metastases. J Thorac Imaging 2011, 26:W1-W3.
    • (2011) J Thorac Imaging , vol.26
    • Mohammed, T.L.1    Chowdhry, A.2    Reddy, G.P.3
  • 33
    • 45549089411 scopus 로고    scopus 로고
    • Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee
    • Meyer JS, Nadel HR, Marina N, et al. Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee. Pediatr Blood Cancer 2008, 51:163-170.
    • (2008) Pediatr Blood Cancer , vol.51 , pp. 163-170
    • Meyer, J.S.1    Nadel, H.R.2    Marina, N.3
  • 34
    • 0022632860 scopus 로고
    • MRI and CT evaluation of primary bone and soft-tissue tumors
    • Aisen AM, Martel W, Braunstein EM, et al. MRI and CT evaluation of primary bone and soft-tissue tumors. Am J Roentgenol 1986, 146:749-756.
    • (1986) Am J Roentgenol , vol.146 , pp. 749-756
    • Aisen, A.M.1    Martel, W.2    Braunstein, E.M.3
  • 35
    • 0023837535 scopus 로고
    • Soft-tissue sarcomas of the extremities: comparison of MR and CT in determining the extent of disease
    • Demas BE, Heelan RT, Lane J, et al. Soft-tissue sarcomas of the extremities: comparison of MR and CT in determining the extent of disease. Am J Roentgenol 1988, 150:615-620.
    • (1988) Am J Roentgenol , vol.150 , pp. 615-620
    • Demas, B.E.1    Heelan, R.T.2    Lane, J.3
  • 36
    • 0031304588 scopus 로고    scopus 로고
    • Scintigraphically negative skip metastasis in osteosarcoma
    • Bhagia SM, Grimer RJ, Davies AM, Mangham DC Scintigraphically negative skip metastasis in osteosarcoma. Eur Radiol 1997, 7:1446-1448.
    • (1997) Eur Radiol , vol.7 , pp. 1446-1448
    • Bhagia, S.M.1    Grimer, R.J.2    Davies, A.M.3    Mangham, D.C.4
  • 37
    • 0033865698 scopus 로고    scopus 로고
    • FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy
    • Franzius C, Sciuk J, Daldrup-Link HE, Jurgens H, Schober O FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med 2000, 27:1305-1311.
    • (2000) Eur J Nucl Med , vol.27 , pp. 1305-1311
    • Franzius, C.1    Sciuk, J.2    Daldrup-Link, H.E.3    Jurgens, H.4    Schober, O.5
  • 38
    • 0035019053 scopus 로고    scopus 로고
    • FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT
    • Franzius C, Daldrup-Link HE, Sciuk J, et al. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol 2001, 12:479-486.
    • (2001) Ann Oncol , vol.12 , pp. 479-486
    • Franzius, C.1    Daldrup-Link, H.E.2    Sciuk, J.3
  • 40
    • 1242307295 scopus 로고    scopus 로고
    • The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis
    • Bastiaannet E, Groen H, Jager PL, et al. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev 2004, 30:83-101.
    • (2004) Cancer Treat Rev , vol.30 , pp. 83-101
    • Bastiaannet, E.1    Groen, H.2    Jager, P.L.3
  • 41
    • 0034054766 scopus 로고    scopus 로고
    • Clinical value of 18-Ffluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas
    • Schwarzbach MH, Dimitrakopoulou-Strauss A, Willeke F, et al. Clinical value of 18-Ffluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas. Ann Surg 2000, 231:380-386.
    • (2000) Ann Surg , vol.231 , pp. 380-386
    • Schwarzbach, M.H.1    Dimitrakopoulou-Strauss, A.2    Willeke, F.3
  • 42
    • 54349098061 scopus 로고    scopus 로고
    • Preoperative core biopsy of soft tissue tumours facilitates their surgical management: a 10-year update
    • Woon DT, Serpell JW Preoperative core biopsy of soft tissue tumours facilitates their surgical management: a 10-year update. ANZ J Surg 2008, 78:977-981.
    • (2008) ANZ J Surg , vol.78 , pp. 977-981
    • Woon, D.T.1    Serpell, J.W.2
  • 44
    • 18244381541 scopus 로고    scopus 로고
    • Accuracy of computed tomography guided core needle biopsy of musculoskeletal tumours
    • Altuntas AO, Slavin J, Smith PJ, et al. Accuracy of computed tomography guided core needle biopsy of musculoskeletal tumours. ANZ J Surg 2005, 75:187-191.
    • (2005) ANZ J Surg , vol.75 , pp. 187-191
    • Altuntas, A.O.1    Slavin, J.2    Smith, P.J.3
  • 45
    • 70449519138 scopus 로고    scopus 로고
    • Biopsy of soft tissue masses: evidence-based medicine for the musculoskeletal tumor society
    • Rougraff BT, Aboulafia A, Biermann JS, Healey J Biopsy of soft tissue masses: evidence-based medicine for the musculoskeletal tumor society. Clin Orthop Relat Res 2009, 467:2783-2791.
    • (2009) Clin Orthop Relat Res , vol.467 , pp. 2783-2791
    • Rougraff, B.T.1    Aboulafia, A.2    Biermann, J.S.3    Healey, J.4
  • 46
    • 0342368637 scopus 로고    scopus 로고
    • Fine needle aspiration biopsy of primary bone tumors
    • Ward WG, Kilpatrick S Fine needle aspiration biopsy of primary bone tumors. Clin Orthop Relat Res 2000, 373:80-87.
    • (2000) Clin Orthop Relat Res , vol.373 , pp. 80-87
    • Ward, W.G.1    Kilpatrick, S.2
  • 50
    • 73349131509 scopus 로고    scopus 로고
    • Molecular diagnosis of Ewing sarcoma family of tumors: a comparative analysis of 560 cases with FISH and RT-PCR
    • Machado I, Noguera R, Pellin A, et al. Molecular diagnosis of Ewing sarcoma family of tumors: a comparative analysis of 560 cases with FISH and RT-PCR. Diagn Mol Pathol 2009, 18:189-199.
    • (2009) Diagn Mol Pathol , vol.18 , pp. 189-199
    • Machado, I.1    Noguera, R.2    Pellin, A.3
  • 52
    • 0027932782 scopus 로고
    • The Ewing family of tumors-a subgroup of small-round-cell tumors defined by specific chimeric transcripts
    • Delattre O, Zucman J, Melot T, et al. The Ewing family of tumors-a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994, 331:294-299.
    • (1994) N Engl J Med , vol.331 , pp. 294-299
    • Delattre, O.1    Zucman, J.2    Melot, T.3
  • 53
    • 0032053388 scopus 로고    scopus 로고
    • Structural analysis of PAX3 genomic rearrangements in alveolar rhabdomyosarcoma
    • Barr FG, Nauta LE, Hollows JC Structural analysis of PAX3 genomic rearrangements in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet 1998, 102:32-39.
    • (1998) Cancer Genet Cytogenet , vol.102 , pp. 32-39
    • Barr, F.G.1    Nauta, L.E.2    Hollows, J.C.3
  • 54
    • 70349451845 scopus 로고    scopus 로고
    • Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas
    • Italiano A, Bianchini L, Gjernes E, et al. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas. Clin Cancer Res 2009, 15:5696-5703.
    • (2009) Clin Cancer Res , vol.15 , pp. 5696-5703
    • Italiano, A.1    Bianchini, L.2    Gjernes, E.3
  • 55
    • 79952216562 scopus 로고    scopus 로고
    • Liposarcoma: molecular genetics and therapeutics
    • Conyers R, Young S, Thomas DM Liposarcoma: molecular genetics and therapeutics. Sarcoma 2011, 2011:483154.
    • (2011) Sarcoma , vol.2011 , pp. 483154
    • Conyers, R.1    Young, S.2    Thomas, D.M.3
  • 56
    • 0031962230 scopus 로고    scopus 로고
    • Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity
    • Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998, 16:197-203.
    • (1998) J Clin Oncol , vol.16 , pp. 197-203
    • Yang, J.C.1    Chang, A.E.2    Baker, A.R.3
  • 57
    • 0037193834 scopus 로고    scopus 로고
    • Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
    • O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002, 359:2235-2241.
    • (2002) Lancet , vol.359 , pp. 2235-2241
    • O'Sullivan, B.1    Davis, A.M.2    Turcotte, R.3
  • 58
    • 12744280714 scopus 로고    scopus 로고
    • Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas
    • DeLaney TF, Trofimov AV, Engelsman M, Suit HD Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas. Cancer Control 2005, 12:27-35.
    • (2005) Cancer Control , vol.12 , pp. 27-35
    • DeLaney, T.F.1    Trofimov, A.V.2    Engelsman, M.3    Suit, H.D.4
  • 59
    • 0033557981 scopus 로고    scopus 로고
    • Pelvic Ewing sarcoma: a retrospective analysis of 241 cases
    • Hoffmann C, Ahrens S, Dunst J, et al. Pelvic Ewing sarcoma: a retrospective analysis of 241 cases. Cancer 1999, 85:869-877.
    • (1999) Cancer , vol.85 , pp. 869-877
    • Hoffmann, C.1    Ahrens, S.2    Dunst, J.3
  • 60
    • 30544442756 scopus 로고    scopus 로고
    • Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era
    • La TH, Meyers PA, Wexler LH, et al. Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era. Int J Radiat Oncol Biol Phys 2006, 64:544-550.
    • (2006) Int J Radiat Oncol Biol Phys , vol.64 , pp. 544-550
    • La, T.H.1    Meyers, P.A.2    Wexler, L.H.3
  • 61
    • 0037963263 scopus 로고    scopus 로고
    • Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome
    • Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome. Int J Radiat Oncol Biol Phys 2003, 56:482-488.
    • (2003) Int J Radiat Oncol Biol Phys , vol.56 , pp. 482-488
    • Zagars, G.K.1    Ballo, M.T.2    Pisters, P.W.3    Pollock, R.E.4    Patel, S.R.5    Benjamin, R.S.6
  • 62
    • 0037112244 scopus 로고    scopus 로고
    • Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma
    • Davis AM, O'Sullivan B, Bell RS, et al. Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol 2002, 20:4472-4477.
    • (2002) J Clin Oncol , vol.20 , pp. 4472-4477
    • Davis, A.M.1    O'Sullivan, B.2    Bell, R.S.3
  • 63
    • 20944438542 scopus 로고    scopus 로고
    • Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma
    • Davis AM, O'Sullivan B, Turcotte R, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 2005, 75:48-53.
    • (2005) Radiother Oncol , vol.75 , pp. 48-53
    • Davis, A.M.1    O'Sullivan, B.2    Turcotte, R.3
  • 66
    • 49049089340 scopus 로고    scopus 로고
    • A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma
    • Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 2008, 113:573-581.
    • (2008) Cancer , vol.113 , pp. 573-581
    • Pervaiz, N.1    Colterjohn, N.2    Farrokhyar, F.3    Tozer, R.4    Figueredo, A.5    Ghert, M.6
  • 67
    • 84866901248 scopus 로고    scopus 로고
    • Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
    • Woll PJ, Reichardt P, Le Cesne A, et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol 2012, 13:1045-1054.
    • (2012) Lancet Oncol , vol.13 , pp. 1045-1054
    • Woll, P.J.1    Reichardt, P.2    Le Cesne, A.3
  • 68
    • 0028334634 scopus 로고
    • Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
    • Bramwell V, Rouesse J, Steward W, et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1994, 12:1137-1149.
    • (1994) J Clin Oncol , vol.12 , pp. 1137-1149
    • Bramwell, V.1    Rouesse, J.2    Steward, W.3
  • 69
    • 61649089629 scopus 로고    scopus 로고
    • The end of adjuvant chemotherapy (adCT) era with doxorubicin-based regimen in resected high-grade soft tissue sarcoma (STS): pooled analysis of the two STBSG-EORTC phase III clinical trials
    • Le Cesne A, Van Glabbeke M, Woll PJ, et al. The end of adjuvant chemotherapy (adCT) era with doxorubicin-based regimen in resected high-grade soft tissue sarcoma (STS): pooled analysis of the two STBSG-EORTC phase III clinical trials. J Clin Oncol 2008, 26(suppl 15):10525.
    • (2008) J Clin Oncol , vol.26 , Issue.SUPPL. 15 , pp. 10525
    • Le Cesne, A.1    Van Glabbeke, M.2    Woll, P.J.3
  • 70
    • 9444228341 scopus 로고    scopus 로고
    • Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma
    • Grobmyer SR, Maki RG, Demetri GD, et al. Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol 2004, 15:1667-1672.
    • (2004) Ann Oncol , vol.15 , pp. 1667-1672
    • Grobmyer, S.R.1    Maki, R.G.2    Demetri, G.D.3
  • 71
    • 0035003544 scopus 로고    scopus 로고
    • A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma
    • Gortzak E, Azzarelli A, Buesa J, et al. A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma. Eur J Cancer 2001, 37:1096-1103.
    • (2001) Eur J Cancer , vol.37 , pp. 1096-1103
    • Gortzak, E.1    Azzarelli, A.2    Buesa, J.3
  • 72
    • 61649093785 scopus 로고    scopus 로고
    • Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group
    • Italiano A, Penel N, Robin YM, et al. Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group. Ann Oncol 2009, 20:425-430.
    • (2009) Ann Oncol , vol.20 , pp. 425-430
    • Italiano, A.1    Penel, N.2    Robin, Y.M.3
  • 73
    • 0023176119 scopus 로고
    • Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas
    • Borden EC, Amato DA, Rosenbaum C, et al. Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol 1987, 5:840-850.
    • (1987) J Clin Oncol , vol.5 , pp. 840-850
    • Borden, E.C.1    Amato, D.A.2    Rosenbaum, C.3
  • 74
    • 84861555286 scopus 로고    scopus 로고
    • WHO, (accessed Aug 14, 2013).
    • WHO model list of essential medicines WHO, (accessed Aug 14, 2013). http://www.who.int/medicines/publications/essentialmedicines/en/index.html.
    • WHO model list of essential medicines
  • 75
    • 0030912403 scopus 로고    scopus 로고
    • High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies-dose-response and schedule dependence
    • Patel SR, Vadhan-Raj S, Papadopolous N, et al. High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies-dose-response and schedule dependence. J Clin Oncol 1997, 15:2378-2384.
    • (1997) J Clin Oncol , vol.15 , pp. 2378-2384
    • Patel, S.R.1    Vadhan-Raj, S.2    Papadopolous, N.3
  • 76
    • 0024513428 scopus 로고
    • Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma
    • Antman KH, Ryan L, Elias A, Sherman D, Grier HE Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma. J Clin Oncol 1989, 7:126-131.
    • (1989) J Clin Oncol , vol.7 , pp. 126-131
    • Antman, K.H.1    Ryan, L.2    Elias, A.3    Sherman, D.4    Grier, H.E.5
  • 77
    • 0036892122 scopus 로고    scopus 로고
    • Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients
    • van Oosterom AT, Mouridsen HT, Nielsen OS, et al. Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients. Eur J Cancer 2002, 38:2397-2406.
    • (2002) Eur J Cancer , vol.38 , pp. 2397-2406
    • van Oosterom, A.T.1    Mouridsen, H.T.2    Nielsen, O.S.3
  • 78
    • 0030726408 scopus 로고    scopus 로고
    • Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas
    • Palumbo R, Palmeri S, Antimi M, et al. Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas. Ann Oncol 1997, 8:1159-1162.
    • (1997) Ann Oncol , vol.8 , pp. 1159-1162
    • Palumbo, R.1    Palmeri, S.2    Antimi, M.3
  • 79
    • 84921702657 scopus 로고    scopus 로고
    • Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma
    • Sarcoma Disease Site Group, CD003293.
    • Bramwell VH, Anderson D, Charette ML Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma. Cochrane Database Syst Rev 2003, 3. Sarcoma Disease Site Group, CD003293.
    • (2003) Cochrane Database Syst Rev , vol.3
    • Bramwell, V.H.1    Anderson, D.2    Charette, M.L.3
  • 80
    • 0037096747 scopus 로고    scopus 로고
    • Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial
    • Hensley ML, Maki R, Venkatraman E, et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 2002, 20:2824-2831.
    • (2002) J Clin Oncol , vol.20 , pp. 2824-2831
    • Hensley, M.L.1    Maki, R.2    Venkatraman, E.3
  • 81
    • 33745444832 scopus 로고    scopus 로고
    • Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis
    • Bay JO, Ray-Coquard I, Fayette J, et al. Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis. Int J Cancer 2006, 119:706-711.
    • (2006) Int J Cancer , vol.119 , pp. 706-711
    • Bay, J.O.1    Ray-Coquard, I.2    Fayette, J.3
  • 82
    • 70249101414 scopus 로고    scopus 로고
    • Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules
    • Demetri GD, Chawla SP, von Mehren M, et al. Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules. J Clin Oncol 2009, 27:4188-4196.
    • (2009) J Clin Oncol , vol.27 , pp. 4188-4196
    • Demetri, G.D.1    Chawla, S.P.2    von Mehren, M.3
  • 83
    • 55949086834 scopus 로고    scopus 로고
    • Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study
    • Penel N, Bui BN, Bay JO, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol 2008, 26:5269-5274.
    • (2008) J Clin Oncol , vol.26 , pp. 5269-5274
    • Penel, N.1    Bui, B.N.2    Bay, J.O.3
  • 84
    • 84861098484 scopus 로고    scopus 로고
    • Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
    • van der Graaf WT, Blay JY, Chawla SP, et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2012, 379:1879-1886.
    • (2012) Lancet , vol.379 , pp. 1879-1886
    • van der Graaf, W.T.1    Blay, J.Y.2    Chawla, S.P.3
  • 85
    • 14144256775 scopus 로고    scopus 로고
    • Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225
    • McArthur GA, Demetri GD, Van Oosterom A, et al. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. J Clin Oncol 2005, 23:866-873.
    • (2005) J Clin Oncol , vol.23 , pp. 866-873
    • McArthur, G.A.1    Demetri, G.D.2    Van Oosterom, A.3
  • 86
    • 0037103424 scopus 로고    scopus 로고
    • Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
    • Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002, 347:472-480.
    • (2002) N Engl J Med , vol.347 , pp. 472-480
    • Demetri, G.D.1    von Mehren, M.2    Blanke, C.D.3
  • 87
    • 0043246702 scopus 로고    scopus 로고
    • Predictive pathology: a pathologist's perspective
    • Waring P Predictive pathology: a pathologist's perspective. Cancer Forum 2003, 27:100-101.
    • (2003) Cancer Forum , vol.27 , pp. 100-101
    • Waring, P.1
  • 88
    • 84876171885 scopus 로고    scopus 로고
    • India's patent case victory rattles Big Pharma
    • Chatterjee P India's patent case victory rattles Big Pharma. Lancet 2013, 381:1263.
    • (2013) Lancet , vol.381 , pp. 1263
    • Chatterjee, P.1
  • 89
    • 84861214958 scopus 로고    scopus 로고
    • Rhabdomyosarcoma: review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies
    • Malempati S, Hawkins DS Rhabdomyosarcoma: review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies. Pediatr Blood Cancer 2012, 59:5-10.
    • (2012) Pediatr Blood Cancer , vol.59 , pp. 5-10
    • Malempati, S.1    Hawkins, D.S.2
  • 90
    • 0037456435 scopus 로고    scopus 로고
    • Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone
    • Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003, 348:694-701.
    • (2003) N Engl J Med , vol.348 , pp. 694-701
    • Grier, H.E.1    Krailo, M.D.2    Tarbell, N.J.3
  • 91
    • 70249094258 scopus 로고    scopus 로고
    • Methotrexate for high-grade osteosarcoma in children and young adults
    • CD006325.
    • Van Dalen EC, de Camargo B Methotrexate for high-grade osteosarcoma in children and young adults. Cochrane Database Syst Rev 2009, 1. CD006325.
    • (2009) Cochrane Database Syst Rev , vol.1
    • Van Dalen, E.C.1    de Camargo, B.2
  • 92
    • 33644837672 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups
    • Ferrari S, Smeland S, Mercuri M, et al. Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 2005, 23:8845-8852.
    • (2005) J Clin Oncol , vol.23 , pp. 8845-8852
    • Ferrari, S.1    Smeland, S.2    Mercuri, M.3
  • 93
    • 0038688477 scopus 로고    scopus 로고
    • Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols
    • Kager L, Zoubek A, Potschger U, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2003, 21:2011-2018.
    • (2003) J Clin Oncol , vol.21 , pp. 2011-2018
    • Kager, L.1    Zoubek, A.2    Potschger, U.3
  • 94
    • 0025008189 scopus 로고
    • Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study
    • Nesbit ME, Gehan EA, Burgert EO, et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol 1990, 8:1664-1674.
    • (1990) J Clin Oncol , vol.8 , pp. 1664-1674
    • Nesbit, M.E.1    Gehan, E.A.2    Burgert, E.O.3
  • 95
    • 0034005161 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine years
    • Bacci G, Ferrari S, Comandone A, et al. Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine years. Acta Oncol 2000, 39:111-116.
    • (2000) Acta Oncol , vol.39 , pp. 111-116
    • Bacci, G.1    Ferrari, S.2    Comandone, A.3
  • 96
    • 10744231796 scopus 로고    scopus 로고
    • Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992
    • Bacci G, Forni C, Longhi A, et al. Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer 2004, 40:73-83.
    • (2004) Eur J Cancer , vol.40 , pp. 73-83
    • Bacci, G.1    Forni, C.2    Longhi, A.3
  • 97
    • 33646859458 scopus 로고    scopus 로고
    • Ewing's sarcoma family of tumors: current management
    • Bernstein M, Kovar H, Paulussen M, et al. Ewing's sarcoma family of tumors: current management. Oncologist 2006, 11:503-519.
    • (2006) Oncologist , vol.11 , pp. 503-519
    • Bernstein, M.1    Kovar, H.2    Paulussen, M.3
  • 98
    • 52449094980 scopus 로고    scopus 로고
    • Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment-cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients
    • Paulussen M, Craft AW, Lewis I, et al. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment-cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. J Clin Oncol 2008, 26:4385-4393.
    • (2008) J Clin Oncol , vol.26 , pp. 4385-4393
    • Paulussen, M.1    Craft, A.W.2    Lewis, I.3
  • 99
    • 33748476296 scopus 로고    scopus 로고
    • Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Societe Francaise des Cancers de l'Enfant
    • Oberlin O, Rey A, Desfachelles AS, et al. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Societe Francaise des Cancers de l'Enfant. J Clin Oncol 2006, 24:3997-4002.
    • (2006) J Clin Oncol , vol.24 , pp. 3997-4002
    • Oberlin, O.1    Rey, A.2    Desfachelles, A.S.3
  • 100
    • 0035368059 scopus 로고    scopus 로고
    • High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis
    • Meyers PA, Krailo MD, Ladanyi M, et al. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. J Clin Oncol 2001, 19:2812-2820.
    • (2001) J Clin Oncol , vol.19 , pp. 2812-2820
    • Meyers, P.A.1    Krailo, M.D.2    Ladanyi, M.3
  • 101
    • 0029073772 scopus 로고
    • Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry
    • Ladenstein R, Lasset C, Pinkerton R, et al. Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry. Bone Marrow Transplant 1995, 15:697-705.
    • (1995) Bone Marrow Transplant , vol.15 , pp. 697-705
    • Ladenstein, R.1    Lasset, C.2    Pinkerton, R.3
  • 102
    • 79952020083 scopus 로고    scopus 로고
    • High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma-a systematic review
    • Peinemann F, Kroger N, Bartel C, et al. High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma-a systematic review. PLoS One 2011, 6:e17127.
    • (2011) PLoS One , vol.6
    • Peinemann, F.1    Kroger, N.2    Bartel, C.3
  • 104
    • 77954031237 scopus 로고    scopus 로고
    • Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects
    • Janeway KA, Grier HE Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects. Lancet Oncol 2010, 11:670-678.
    • (2010) Lancet Oncol , vol.11 , pp. 670-678
    • Janeway, K.A.1    Grier, H.E.2
  • 105
    • 0027082303 scopus 로고
    • A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup
    • Bramwell VH, Burgers M, Sneath R, et al. A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. J Clin Oncol 1992, 10:1579-1591.
    • (1992) J Clin Oncol , vol.10 , pp. 1579-1591
    • Bramwell, V.H.1    Burgers, M.2    Sneath, R.3
  • 106
    • 80054914908 scopus 로고    scopus 로고
    • Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?
    • Anninga JK, Gelderblom H, Fiocco M, et al. Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?. Eur J Cancer 2011, 47:2431-2445.
    • (2011) Eur J Cancer , vol.47 , pp. 2431-2445
    • Anninga, J.K.1    Gelderblom, H.2    Fiocco, M.3
  • 107
    • 84869447819 scopus 로고    scopus 로고
    • Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group
    • Womer RB, West DC, Krailo MD, et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol 2012, 30:4148-4154.
    • (2012) J Clin Oncol , vol.30 , pp. 4148-4154
    • Womer, R.B.1    West, D.C.2    Krailo, M.D.3
  • 108
    • 34547186749 scopus 로고    scopus 로고
    • Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies
    • Rodriguez-Galindo C, Liu T, Krasin MJ, et al. Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies. Cancer 2007, 110:375-384.
    • (2007) Cancer , vol.110 , pp. 375-384
    • Rodriguez-Galindo, C.1    Liu, T.2    Krasin, M.J.3
  • 110
    • 84874106283 scopus 로고    scopus 로고
    • Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy
    • Min D, Lin F, Shen Z, et al. Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy. Asia Pac J Clin Oncol 2013, 9:71-79.
    • (2013) Asia Pac J Clin Oncol , vol.9 , pp. 71-79
    • Min, D.1    Lin, F.2    Shen, Z.3
  • 111
    • 33947181705 scopus 로고    scopus 로고
    • WHO, (accessed Oct 2, 2013).
    • WHO's pain ladder WHO, (accessed Oct 2, 2013). http://www.who.int/cancer/palliative/painladder/en/.
    • WHO's pain ladder
  • 112
    • 84874954241 scopus 로고    scopus 로고
    • SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries
    • Chantada G, Luna-Fineman S, Sitorus RS, et al. SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries. Pediatr Blood Cancer 2013, 60:719-727.
    • (2013) Pediatr Blood Cancer , vol.60 , pp. 719-727
    • Chantada, G.1    Luna-Fineman, S.2    Sitorus, R.S.3
  • 113
    • 79960892299 scopus 로고    scopus 로고
    • Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group
    • Mostert S, Arora RS, Arreola M, et al. Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group. Lancet Oncol 2011, 12:719-720.
    • (2011) Lancet Oncol , vol.12 , pp. 719-720
    • Mostert, S.1    Arora, R.S.2    Arreola, M.3
  • 114
    • 84870219145 scopus 로고    scopus 로고
    • Chemotherapy compliance in patients with osteosarcoma
    • Bajpai J, Puri A, Shah K, et al. Chemotherapy compliance in patients with osteosarcoma. Pediatr Blood Cancer 2013, 60:41-44.
    • (2013) Pediatr Blood Cancer , vol.60 , pp. 41-44
    • Bajpai, J.1    Puri, A.2    Shah, K.3
  • 115
    • 84866147628 scopus 로고    scopus 로고
    • Suboptimal chemotherapy is an adverse prognostic factor in osteosarcoma
    • Yong B, Tan P, Yin J, et al. Suboptimal chemotherapy is an adverse prognostic factor in osteosarcoma. World J Surg Oncol 2012, 10:191.
    • (2012) World J Surg Oncol , vol.10 , pp. 191
    • Yong, B.1    Tan, P.2    Yin, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.